-
Mashup Score: 0
A randomised trial investigating preventive ablation of a potential arrhythmogenic substrate associated with coronary CTO in patients at high risk of ventricular arrhythmias has found that this approach may reduce the risk of appropriate ICD therapy and unplanned hospitalisation.
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2High-power short-duration ablation protocol “reduces procedure times” - Cardiac Rhythm News - 1 year(s) ago
High-power short-duration ablation results in significantly shorter procedure times without affecting procedural efficacy and safety among patients undergoing ablation for atrial fibrillation (AF). This is according to the findings of a single-centre study investigating the impact of high-density mapping alongside high-power short-duration ablation protocols on the timing, efficacy and safety of the procedures, in which […]
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet-
High-power short-duration ablation protocol “reduces procedure times” https://t.co/sKAiHpguig
-
-
Mashup Score: 26Varipulse PFA system receives CE mark - 1 year(s) ago
Biosense Webster has announced the receipt of European CE mark approval for the Varipulse platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AF) using pulsed field ablation (PFA).
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet-
NEW: @BiosenseWebster Webster announces CE mark for the Varipulse pulsed field ablation system for the treatment of symptomatic drug refractory recurrent paroxysmal, making it the latest #PFA device to gain regulatory approval https://t.co/2AAvBi6QFB
-
-
Mashup Score: 0AHA acknowledges potential and pitfalls for AI in cardiovascular medicine - Cardiac Rhythm News - 1 year(s) ago
A scientific statement published by the American Heart Association (AHA) in Circulation today acknowledges the potential “transformative” impact of the technology on cardiovascular medicine, but challenges remain in its development, the authors of the paper state. The new scientific statement, “Use of Artificial Intelligence in Improving Outcomes in Heart Disease,” comes amid intense attention on […]
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet-
AHA acknowledges potential and pitfalls for AI in cardiovascular medicine https://t.co/XQ4qw3vpNF
-
-
Mashup Score: 2Advertorial: Arrival of PFA “may widen accessibility” of ablation for AF patients - Cardiac Rhythm News - 1 year(s) ago
This advertorial is sponsored by Biosense Webster The field of catheter ablation for atrial fibrillation (AF) is evolving. The development of pulsed field ablation (PFA), as well as advances in established technologies such as radiofrequency (RF) ablation, help catheter ablation to offer a promising confluence of safety, efficacy and efficiency in arrhythmia treatment.1 Given the global […]
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet-
The arrival of pulsed field ablation “may widen accessibility” of ablation for AF patients @VivekReddyMD tells @CRN_publishing in this advertorial, sponsored by @BiosenseWebster Read more here: https://t.co/0sfnabUfTG
-
-
Mashup Score: 50Boston Scientific’s Farapulse PFA system gains US FDA approval - 1 year(s) ago
Boston Scientific has received US Food and Drug Administration (FDA) approval for the Farapulse pulsed field ablation (PFA) system.
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet-
More pulsed field ablation news as Boston Scientific gains US FDA approval for its Farapulse PFA system https://t.co/KAEwfPNyJW
-
-
Mashup Score: 100
Abbott has announced the first global procedures have been conducted using the company’s new Volt pulsed field ablation system to treat patients with arrhythmias such as atrial fibrillation (AF).
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet-
.@AbbottCardio is the latest entrant into the growing pulsed field ablation market, announcing the first procedures conducted using its Volt PFA system as part of a CE mark study https://t.co/UGbWYl5f94
-
-
Mashup Score: 5
Biosense Webster has today announced approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the Varipulse platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AF) using pulsed field ablation (PFA). The Varipulse platform is comprised of the Varipulse catheter, a variable-loop multielectrode catheter; the Trupulse generator, a multichannel […]
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet-
The Varipulse PFA system from @BiosenseWebster has been approved for use in refractory recurrent paroxysmal by Japan's @MHLWitter_en - the first approval of its kind in the country https://t.co/KJ5k3g1vHw
-
-
Mashup Score: 6
Medtronic has received CE mark for its Micra AV2 and Micra VR2, the next generation of its miniature, leadless pacemakers.
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet-
Medtronic has received CE mark for its Micra AV2 and Micra VR2, the next generation of its miniature, leadless pacemakers https://t.co/nIJz1pqCzg
-
-
Mashup Score: 2Medtronic’s PulseSelect PFA system gains US FDA approval - 2 year(s) ago
Medtronic has announced that the US FDA has approved the PulseSelect PFA system for the treatment of both paroxysmal and persistent AF.
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet-
The PulseSelect pulsed field ablation system from @Medtronic has gained US Food and Drug Administration approval, coming soon after the receipt of CE mark for the device https://t.co/ybsW1y52Qq
-
Late-breaking results of PREVENTIVE-VT from @ukclj show that a preventive ablation approach could cut the risk of ICD therapy and unplanned hospitalisation in patients at high risk of ventricular arrhythmias https://t.co/sFUIvgBiCf